Clinical trial
Evaluation of the Safety and Efficacy of Oral Ibuprofen in Term 20-28 Days Old Newborns Referred to Bandar Abbass Children Hospital in 2011
NCT01511887 is registered in ClinicalTrials.gov with Hormozgan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Efficacy of Oral Ibuprofen in Term 20-28 Days Old Newborns Referred to Bandar Abbass Children Hospital in 2011
- Lead sponsor
- Hormozgan University of Medical Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- January 31, 2012
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patent ductus arteriosus